Updated Saturday, July 21, 2018
 Journal Tools
RSS Feed
Sample Copy
Submit a Manuscript
Contact Us
Subscription
Advertising
Thanking Peer Reviewers
 Language Polishing
Journal of Integrative Medicine: Volume 11, 2013   Issue 6,  Pages: 389-396

DOI: 10.3736/jintegrmed2013039
Research Article
Mechanism of resveratrol on the promotion of induced pluripotent stem cells
1. Dao-fang Ding (Institute of Spine, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China )
2. Xiao-feng Li (Institute of Spine, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China )
3. Hao Xu (Institute of Spine, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China )
4. Zhen Wang (Laboratory of Cancer Hospital, Fudan University, Shanghai 200032, China )
5. Qian-qian Liang (Institute of Spine, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China )
6. Chen-guang Li (Institute of Spine, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China )
7. Yong-jun Wang (Institute of Spine, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China E-mail: yjwang88@hotmail.)

OBJECTIVE: To investigate the effects of resveratrol (RV) in reprogramming mouse embryonic fibroblasts (MEFs) into induced pluripotent stem cells (iPSCs) and the related mechanism.

METHODS: Primary MEFs were isolated from E13.5 embryos and used within three passages. Retroviruses expressing Sox2 and Oct4 were produced by transfecting GP2-293t cells with recombinant plasmids murine stem cell virus (MSCV)-Sox2 and MSCV-Oct4. Supernatants containing retroviruses were obtained after 48-hour transfection and MEFs were then infected. Different concentrations (0, 5, 10 and 20 μmol/L) of RV were added to embryonic stem cell (ESC) medium to culture MEFs 48 h post-infection. iPSC clones emerged and were further cultured. Expression of pluripotent markers of iPSCs was identified by cell immunofluorescence and reverse transcription-polymerase chain reaction. Both cytotoxicity and cell proliferation were assayed by Western blot analysis after RV was added into ESC medium. The ultrastructure change of mitochondria was observed by electron microscopy.

RESULTS: More than 2.9-fold and 1.3-fold increases in colony number were observed by treatment with RV at 5 and 10 μmol/L, respectively. The reprogramming efficiency was significantly decreased by treatment with 20 μmol/L RV. The proliferation effect on MEFs or MEFs infected by two factors Sox2/Oct4 (2 factors-MEFs, 2F-MEFs) was investigated after RV treatment. At 20 μmol/L RV, induced cell apoptosis and proliferation inhibition were more obvious than those of 5 and 10 μmol/L treatments. Clones were selected from the 10 μmol/L RV-treated group and cultured. Green fluorescent protein expression from one typical clone was silenced one month later which expressed ESC-associated marker genes Gdf3, Nanog, Ecat1, Fgf4 and Foxd3. Electron transmission microscope showed obvious cavitations in mitochondria. The expression of hypoxia-inducible factor-1α was up-regulated when 2F-MEFs were treated with RV compared to the control group.

CONCLUSION: RV improved the efficiency of reprogramming 2F-MEFs into iPSCs at low and moderate concentrations (5 and 10 μmol/L). The effect of 10 μmol/L RV on reprogramming was much greater than that of 5 μmol/L RV. However, high concentration of RV (20 μmol/L) led to more severe cavitations in mitochondria and caused cytotoxic effects. Taken together, these findings suggest that RV mimics hypoxia in cells and promotes reprogramming at a low concentration.

Welcome to JIM! You are the number 21395 reader of this article!
Download Article:
[Full Text]      [PDF]      [Next]      [This Issue]
Please cite this article as:
Ding DF, Li XF, Xu H, Wang Z, Liang QQ, Li CG, Wang YJ. Mechanism of resveratrol on the promotion of induced pluripotent stem cells. J Integr Med. 2013; 11(6): 389-396.
References:
1Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition[J].PLoS Biol, 2008, 6(10): e253.  
2Li W, Wei W, Zhu S, Zhu J, Shi Y, Lin T, Hao E, Hayek A, Deng H, Ding S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors[J].Cell Stem Cell, 2009, 4(1): 16-19.  
3Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds[J].Nat Biotechnol, 2008, 26(7): 795-797.  
4Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, Melton DA. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2[J].Nat Biotechnol, 2008, 26(11): 1269-1275.  
5Marson A, Foreman R, Chevalier B, Bilodeau S, Kahn M, Young RA, Jaenisch R. Wnt signaling promotes reprogramming of somatic cells to pluripotency[J].Cell Stem Cell, 2008, 3(2): 132-135.  
6Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, Wrana JL. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming[J].Cell Stem Cell, 2010, 7(1): 64-77.  
7Chen J, Liu J, Yang J, Chen Y, Chen J, Ni S, Song H, Zeng L, Ding K, Pei D. BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone[J].Cell Res, 2011, 21(1): 205-212.  
8Esteban MA, Wang T, Qin B, Yang J, Qin D, Cai J, Li W, Weng Z, Chen J, Ni S, Chen K, Li Y, Liu X, Xu J, Zhang S, Li F, He W, Labuda K, Song Y, Peterbauer A, Wolbank S, Redl H, Zhong M, Cai D, Zeng L, Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells[J].Cell Stem Cell, 2010, 6(1): 71-79.  
9Wood LG, Wark PA, Garg ML. Antioxidant and anti-inflammatory effects of resveratrol in airway disease[J].Antioxid Redox Signal, 2010, 13(10): 1535-1548.  
10Pintea A, Rugin? D, Pop R, Bunea A, Socaciu C, Diehl HA. Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells[J].J Ocul Pharmacol Ther, 2011, 27(4): 315-321.  
11Wang H, Yang YJ, Qian HY, Zhang Q, Xu H, Li JJ. Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev. 2012; 17(3): 437-448.
12Chen T, Shen L, Yu J, Wan H, Guo A, Chen J, Long Y, Zhao J, Pei G. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells[J].Aging Cell, 2011, 10(5): 908-911.  
13Aziz MH, Kumar R, Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms[J].Int J Oncol, 2003, 23(1): 17-28.  
14Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes[J].Science, 1997, 275(5297): 218-220.  
15Jazzier AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin’s lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis[J].Mol Cancer Ther, 2004, 3(1): 71-84.  
16Shih A, Davis FB, Lin HY, Davis PJ. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK and p53-dependent mechanism[J].J Clin Endocrinol Metab, 2002, 87(3): 1223-1232.  
17Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol[J].Cardiovasc Drug Rev, 2004, 22(3): 169-188.  
18Das S, Das DK. Anti-inflammatory responses of resveratrol[J].Inflamm Allergy Drug Targets, 2007, 6(3): 168-173.  
19de la Lastra CA, Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications[J].Mol Nutr Food Res, 2005, 49(5): 405-430.  
20Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, Endo M, Fujioka T, Tanji S, Mo YY, Cao D, Wilber AC, Watabe K. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase[J].Breast Cancer Res Treat, 2011, 130(2): 387-398.  
21Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and kras transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition[J].PLoS One, 2011, 6(1): e16530.  
22Fischer B, Bavister BD. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits[J].J Reprod Fertil, 1993, 99(2): 673-679.  
23Dumoulin JC, Meijers CJ, Bras M, Coonen E, Geraedts JP, Evers JL. Effect of oxygen concentration on human in-vitro fertilization and embryo culture[J].Hum Reprod, 1999, 14(2): 465-469.  
24Petersen A, Mikkelsen AL, Lindenberg S. The impact of oxygen tension on developmental competence of post-thaw human embryos[J].Acta Obstet Gynecol Scand, 2005, 84(12): 1181-1184.  
25Kovacic B, Vlaisavljevi? V. Influence of atmospheric versus reduced oxygen concentration on development of human blastocysts in vitro: a prospective study on sibling oocytes[J].Reprod Biomed Online, 2008, 17(2): 229-236.  
26Olson SE, Seidel GE Jr. Reduced oxygen tension and EDTA improve bovine zygote development in a chemically defined medium[J].J Anim Sci, 2000, 78(1): 152-157.  
27Harvey AJ, Kind KL, Pantaleon M, Armstrong DT, Thompson JG. Oxygen-regulated gene expression in bovine blastocysts[J].Biol Reprod, 2004, 71(4): 1108-1119.  
28Rinaudo PF, Giritharan G, Talbi S, Dobson AT, Schultz RM. Effects of oxygen tension on gene expression in preimplantation mouse embryos[J].Fertil Steri, 2006, 86(4 Suppl): 1252-1265.  
29Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells[J].Proc Natl Acad Sci U S A, 2005, 102(13): 4783-4788.  
30Westfall SD, Sachdev S, Das P, Hearne LB, Hannink M, Roberts RM, Ezashi T. Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells[J].Stem Cells Dev, 2008, 17(5): 869-881.  
31Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells[J].Cell Stem Cell, 2009, 5(3): 237-241.  
32Ratcliffe PJ. From erythropoietin to oxygen: hypoxia-inducible factor hydroxylases and the hypoxia signal pathway[J].Blood Purif, 2002, 20(5): 445-450.  
This article has been cited by other articles ( within jim ) :
1Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis20143
 Home | Current Issue | Past Issues | SearchRSS
Copyright © 2013-2018 by JIM Editorial Office. All rights reserved. ISSN 2095-4964; CN 31-2083/R. 沪ICP备110264号